[Celecoxib and the CLASS study--worse and worse...].
Slørdal
Lars
L
Institutt for laboratoriemedisin Norges teknisk-naturvitenskapelige universitet Medisinsk teknisk forskningssenter 7489 Trondheim.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D010437:Peptic Ulcer / Q000139:chemically induced; D011720:Pyrazoles; D016032:Randomized Controlled Trials as Topic; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib